Junko Murai
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Molecular Biology top 1%
- DNA Repair Mechanisms
- Cancer therapeutics and mechanisms
- CRISPR and Genetic Engineering
- Cell death mechanisms and regulation
Papers in
-
- DNA Repair Mechanisms 31
- Cancer therapeutics and mechanisms 20
- CRISPR and Genetic Engineering 5
- Signaling Pathways in Disease 4
- TGF-β signaling in diseases 4
- Oncology 47
- PARP inhibition in cancer therapy 37
- Co-authors
- Yves Pommier (45 shared papers)Shunichi Takeda (14 shared papers)James H. Doroshow (6 shared papers)Yiping Zhang (5 shared papers)Jiuping Ji (5 shared papers)Benu Brata Das (4 shared papers)Amèlie Renaud (3 shared papers)Shar-yin N. Huang (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (8 papers)Nucleic Acids Research (5 papers)Cancer Research (5 papers)Clinical Cancer Research (3 papers)Journal of Biological Chemistry (3 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Junko Murai
74 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 4.2k
- Molecular Biology 4.5k
- Reproductive Medicine 378
- Toxicology 111
- Cancer Research 467
Countries citing papers authored by Junko Murai
This map shows the geographic impact of Junko Murai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Murai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Murai more than expected).
Fields of papers citing papers by Junko Murai
This network shows the impact of papers produced by Junko Murai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Murai. The network helps show where Junko Murai may publish in the future.
Co-authors
The 25 scholars most cited alongside Junko Murai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors Hit paper breakdown → | 2012 | 1613 |
| 2 | Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib Hit paper breakdown → | 2013 | 592 |
| 3 | A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress Hit paper breakdown → | 2017 | 379 |
| 4 | 2014 | 262 | |
| 5 | 2016 | 219 | |
| 6 | 2014 | 206 | |
| 7 | 2018 | 182 | |
| 8 | 2014 | 168 | |
| 9 | 2006 | 162 | |
| 10 | 2012 | 152 | |
| 11 | 2019 | 111 | |
| 12 | 2013 | 106 | |
| 13 | 2011 | 98 | |
| 14 | 2018 | 97 | |
| 15 | 2011 | 91 | |
| 16 | 2004 | 91 | |
| 17 | 2012 | 90 | |
| 18 | 2013 | 86 | |
| 19 | 2018 | 75 | |
| 20 | 2015 | 70 |
About Junko Murai
Junko Murai is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 76 papers that have together received 6.0k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (37 papers), DNA Repair Mechanisms (31 papers), Cancer therapeutics and mechanisms (20 papers), CRISPR and Genetic Engineering (5 papers), Signaling Pathways in Disease (4 papers), Integrated Circuits and Semiconductor Failure Analysis (4 papers), Cancer Genomics and Diagnostics (4 papers) and TGF-β signaling in diseases (4 papers). The work is most often cited by research in Oncology (4.2k citations), Molecular Biology (4.5k citations), Reproductive Medicine (378 citations), Toxicology (111 citations) and Cancer Research (467 citations). Junko Murai has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yves Pommier, Shunichi Takeda, James H. Doroshow, Yiping Zhang, Jiuping Ji, Benu Brata Das, Amèlie Renaud, Shar-yin N. Huang, Shar-yin N. Huang and Joel Morris. Their work appears in journals such as Molecular Cancer Therapeutics, Nucleic Acids Research, Cancer Research, Clinical Cancer Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.